Another great distinction for our company!
We are proud of our legal team’s distinction to be among the “Legal 500 2019 General Counsel Powerlist: Greece & Cyprus” that were honored in a reception that took place in Athens on 16 May 2019.
Pharmathen proceeded to new investments and acquired an additional 27-acres land in the Industrial Park of Sapes in order to expand its innovative business.
Pharmathen’s press event for its 50-years milestone
Coming together from all around the globe, we celebrated with our people 50 years of operation...
For yet another year, Pharmathen has been distinguished at the “2018 EU Industrial R&D Investment Scoreboard” and is ranked first among Greek companies based on R&D spending, by investing 33% of its turnover. With annual R&D spending of 49.9 million euros in the 2017-2018 period, Pharmathen ranked 396th on this year’s list of 1,000 companies in the EU with the highest R&D expenditure.
Our participation in CPhI 2018 Worldwide, the world's largest pharmaceutical exhibition, has been a great opportunity for our executives to meet and interact with hundreds of customers and partners coming from around the globe.
For yet another year, Pharmathen participates at CPHI 2018 in Madrid @Stand No 9F31. We look forward to see you there!
Amsterdam, 30/11/2017: Pharmathen, a BC Partners portfolio company, announces the sale of its Greek commercial operations as part of its long-term strategy to become a leader focused on the development of innovative and complex pharmaceuticals.
For yet another year, Pharmathen had an impressive presence at the international exhibition CPhI Worldwide 2017 which took place in Frankfurt, Germany on the 24-26 October 2017.